Measured Wealth Private Client Group, LLC Bristol Myers Squibb CO Transaction History
Measured Wealth Private Client Group, LLC
- $307 Million
- Q4 2024
A detailed history of Measured Wealth Private Client Group, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Measured Wealth Private Client Group, LLC holds 11,164 shares of BMY stock, worth $549,603. This represents 0.21% of its overall portfolio holdings.
Number of Shares
11,164
Previous 5,514
102.47%
Holding current value
$549,603
Previous $285,000
121.4%
% of portfolio
0.21%
Previous 0.1%
Shares
19 transactions
Others Institutions Holding BMY
# of Institutions
2,780Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$9.35 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.81 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$4.73 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$4.68 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$2.97 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $105B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...